Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Arikha Moses

CEO

Concarlo Holdings, LLC

Dr. Moses started her career at a seed-stage venture firm, where she was responsible for sourcing, building, and managing early-stage life science companies including EluSys Therapeutics and TyRx. As TyRx’s Founder and Chief Scientific Officer, she was responsible for the company’s strategy and during her tenure she was involved in all aspects of the company’s business including financing, licensing, product development, corporate partnerships with Boston Scientific and Bard, and the commercialization of multiple drug-eluting devices. TyRx was sold to Medtronic for $160MM. She has also worked with the venture capital firm the Vertical Group as an EIR, where she assisted with due diligence on investments in both private and public companies. While working with Vertical, she founded and led Galatea Surgical, a plastic surgery company, through clinical and commercial product sales.

Arikha holds a PhD in Chemistry from Yale and a BA with Honors in Chemistry from Brandeis University

This speaker's sessions:

Back